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INTRODUCTION
Glioblastoma (GBM) and brain metastasis are the most common
brain neoplasms in adulthood, accounting for about half of all cases
(1, 2). It is critical to distinguish GBM from metastasis for prog-
nosis and optimal treatment. However, differential diagnosis is
generally a challenge using conventional magnetic resonance im-
aging (MRI) because both of these neoplasms show similar im-
aging manifestations, like a solid contrast enhancement with peri-
tumoral edema and a mass effect.
Perfusion MRI is helpful for the assessment of brain tumors by
defining the degree of microvascular proliferation. Studies using
dynamic susceptibility contrast -enhanced (DSC) MRI, the most
prevalent perfusion technique, reported a relatively higher value
for GBM compared with metastasis. This difference stems from
the peritumoral perfusion deficit caused by edema surrounding
metastatic tumors (3-5). However, the presence of tumoral edema
and the difference in perfusion are still insufficient for differen-
tiation due to a high likelihood of elevated perfusion value in
metastasis (6) and tumoral edema in primary gliomas(7).
As an alternative to DSC MRI, arterial spin labeling (ASL) per-
fusion imaging has proven to be reliable for evaluating cerebral
blood circulation. In contrast to standard perfusion imaging with
exogenous contrast agents, ASL uses arterial blood water as an
endogenous tracer to quantify cerebral blood flow (CBF) (8).
Estimation of CBF parameters derived from ASL are used in clini-
cal practice to assess various neurological disorders, including
tumors, stroke, and epilepsy (9, 10). In addition to CBF estimation,
several groups have reported that a high- intensity signal abnor-
mality on ASL images could aid in the diagnosis of cerebrovascular
malformations (11, 12). Furthermore, a recent study conducted
at our institution demonstrated that high signal intensity on ASL
may be used to distinguish histologically distinct tumors (13). In
that investigation, a mismatch in the high- intensity signal area
between ASL and contrast -enhanced imaging was found for pri-
mary gliomas and malignant lymphomas compared to metastasis.
While conventional MRI manifestations are comparable, mecha-
nisms of tumor angiogenesis differ markedly between GBM and
metastasis. GBM is a highly vascular tumor, and microvessels
always infiltrate into surrounding brain tissue (4, 5, 14). In contrast,
there is a lack of angiogenic infiltration into peritumoral tissue in
metastasis (15). ASL is a very sensitive modality for detecting hy-
pervascularity, which appears as high- intensity signals (10). On
the other hand, the main source of estimation errors in ASL imag-
ing is often related to hypoperfused lesions with arterial transit
delay (9).
Various volumetric parameters derived from the high- intensity
signals on traditional MRI sequences, such CE+T1WI, FLAIR, and
T2WI, are used for brain tumor evaluation, especially volumetric
changes in contrast enhancement (16-18). It has been reported
that three-dimensional (3D) volumetry maybe more accurate for
defining tumor volume than estimates based on 2D axial slices
(19).
In this study, we measured the volumes of the ASL high- inten-
sity signals from GBM and metastasis and compared them with
those of CE+T1WI signals, allowing sensitive differentiation of these
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tumor types using the subtracted high- intensity volume (ASL minus
CE+T1WI) and ratio (ASL to CE+T1WI). We have also compared
CBF variables estimated by ASL between the tumor groups.
MATERIALS AND METHOD
This study was approved by the ethics committee of our institu-
tion and informed consent was obtained from all patients before the
examinations.
We selected prospective patients with GBM or metastasis who
had undergone MRI examinations at Tokushima University Hos-
pital between 2010 and 2015. All patients had been evaluated by
ASL and other MRI sequences using the same MRI machine prior
to treatment. Of 41 patients considered for this study, 1 case with
metastasis was excluded due to a visible artifact on ASL images and
2 GBM cases were excluded due to lack of contrast enhancement
on CE+T1WI.
Finally, 38 patients (23 men, 15 women ; age range 43-87 years ;
mean age, 65.26 years) with a diagnosis of GBM or metastasis were
enrolled. All 25 patients with GBM were diagnosed by histopa-
thological examination at surgical resection or biopsy, and histopa-
thological results were used as the reference based on World
Health Organization criteria (20). Of the 13 patients with metasta-
sis, 11 were diagnosed by histopathological examination and 2 were
diagnosed by clinical findings (21). The primary metastatic tumor
was lung carcinoma in 5 patients, breast carcinoma in 3, colon car-
cinoma in 3, urothelial carcinoma in 1, and ovarian carcinoma in 1.
MRI PROTOCOLS
MRI was performed on a 3-T scanner (Discovery 750, GE Health-
care, Milwaukee, WI) using a standard 8-channel head coil. All
MRI examinations included ASL, CE+T1WI, T2WI, FLAIR, T1WI,
and DWI.
CE+T1WI with 3D fast spoiled gradient echo (FSPGR) images
were acquired as following parameter. Four minutes after injection
of 0.1 mmol/kg body weight a gadolinium-containing contrast
agent (gadopentetate dimeglumine Gd-DTPA, Magnevist, Bayer
HealthCare, Berlin, Germany) with a power injector (Medrad Inc,
Indianola, PA, USA) at 2.5 ml/s followed with normal saline (20 ml)
lock-flush at the same rate. Scan parameters for 3D FSPGR were :
TR 10.4 ms, TE 4.4 ms, bandwidth 31.25 kHz, slice thickness 1.2
mm, matrix 384256, flip angle 15, NEX one, field of view (FOV)
2424 cm, acceleration factor 22, number of slices 160, and ac-
quisition time of 3 : 34 min.
ASL was obtained with pseudo-continuous labeling, background
suppression, and a stack of spiral 3D fast -spin echo imaging se-
quences (22). Acquisition parameters were as follows : 512 sam-
pling points on 8 spirals, field of view (FOV) 24 cm, TR 4632 ms,
TE 10.5 ms, reconstructed matrix size 6464, number of excita-
tions 2, post- labeling delay 1525 ms, slice thickness 4 mm, number
of slices 36, and total acquisition time 3 : 15 min.
IMAGING DATA ANALYSIS
We measured the tumor volumes by contrast enhancement on
CE+T1WI and high-signal intensity on ASL images using com-
mercial software (Synapse 3D Vincent, Ver.4.0, Fujifilm, Tokyo,
Japan) with semiautomatic drawing. Volumes of interest (VOIs)
were placed only on the high signal intensity regions of CE+T1WI
and ASL images (Fig. 1). Tumor position on CE+T1WI was used
as the reference for VOI placement on ASL images. We did not
include necrotic areas in tumors and avoided nontumoral tissues.
To reduce sampling errors due to inclusion of surrounding low-
intensity regions within VOIs, we used cutoff values derived from
VOIs encompassing contralateral healthy white matter. For both
CE+T1WI and ASL, cutoff values were defined as the mean+
2standard deviation, which was subtracted from the VOI signal
intensity histogram for each patient.
Next, we calculated the volume difference by subtracting the
high- intensity volume obtained by ASL from the CE+T1WI vol-
ume (ASL tumor volume - CE tumor volume). We also calculated
the volume ratio (ASL volume/CE volume) for each patient.
We investigated CBF parameters such as the absolute maximal
tumor blood flow (TBF) and TBF ratio (normalized to blood flow
in healthy white matter) between tumor groups using the Advan-
tage Window AW 4.6 workstation (GE, Medical Systems, Milwau-
kee, WI). The regions of interest (ROI)’s were placed on maximal
signal intensity areas of the tumor lesions on CE+T1WI and copied
to corresponding ASL maps. All measurements were acquired in-
dependently by two neuroradiologists (M.G and M.H) blinded to
the diagnostic information and averaged for analyses. Only values
with intra-class correlation coefficients (ICC)0.90 (p0.001)
were included in the final analysis.
STATISTICAL ANALYSIS
All statistical analyses were performed using SPSS Ver. 20 (IBM,
Armonk, NY, USA). The Mann-Whitney U test was used to assess
differences in variables between GBM and metastasis. Receiver
operating characteristic (ROC) curve analysis was used to assess
diagnostic accuracy for differentiating GBM from metastasis. The
level of significance was set at p0.05.
RESULTS
Both subtracted tumor volume (ASL-measured volume minus
CE-T1WI-measured volume) and ratio of tumor volume (ASL-
measured volume/CE-T1WI-measured volume) differed signifi-
cantly between the tumor types (Table 1), with subtracted tumor
volume significantly larger for GBM than for metastasis (p0.001).
Similarly, the volumetric ratio was significantly higher for GBM
than for metastasis (p0.001). In contrast, differences in the TBF
and TBF ratio did not reach statistical significance (p=0.85 and p=
0.69, respectively).
The areas under the ROC curves for subtracted tumor volume
and tumor volume ratio were 0.865 and 0.852, respectively (Fig. 2).
Subtracted tumor volume2.7 ml distinguished GBM from me-
tastasis with 96% sensitivity and 76.9% specificity, and a ratio1.14
distinguished GBM from metastasis with 96% sensitivity and 69.2%
specificity. The AUC for TBF was 0.674, with 60% sensitivity and
69.2% specificity. The AUC of the TBF ratio was 0.683, with 56%
sensitivity and 76.9% specificity. Diagnostic accuracy was signifi-
cant for both tumor volume difference and tumor volume ratio (P
0.001 for both) but not for TBF or TBF ratio.
DISCUSSION
The similar imaging manifestations of GBM and metastasis can
complicate differential diagnosis, particularly when metastasis
has a single mass. Survival time and treatment options differ sub-
stantially between GBM and metastasis. Median survival time is
only 12.61 months for GBM and even shorter for metastasis, ne-
cessitating timely and accurate diagnosis. The main treatment for
GBM is immediate removal of as much of the tumor as possible,
followed by radiation and chemotherapy. Metastasis treatment
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options depend on whether there is a single or multiple lesion ;
generally, for patients with a single lesion, surgery is considered
effective, but a recent study concluded that whole brain radiation
therapy combined with stereotactic radiosurgery could be better
(23-25).
In the present study, comparative volumetric assessment using
ASL and CE+T1WI differentiated GBM from metastasis with clini-
cal significance. ROC analysis (Fig. 2) showed that both volume
difference and volume ratio were higher for GBM compared with
metastatic tumors. The area under the ROC curve was highest for
subtracted tumor volume (0.865) and lowest for TBF (0.674), and
both TBF and TBF ratio were less sensitive and specific indicators
of tumor type than were volumetric parameters. In sum, a larger
high- intensity signal volume on ASL compared with CE volume is
suggestive of GBM, while a smaller volume difference suggests
metastasis.
It is well known that ASL signal intensity is strongly correlated
with tumor vascularity, allowing histopathological tumor diagnosis
and grading (9, 10, 26). The extensive tumor angiogenesis asso-
ciated with GBM (neovascularization) results in vascular abnor-
malities such as microvessel proliferation, endothelial hyperplasia,
vessel dilation, and high vessel tortuosity. GBM generally grows
diffusely into normal brain tissue due to the rich vascular network
created (14, 24, 27). In contrast, vascularity of metastasis is mostly
resembled the vessels of primary site tumors and microvessel
density is only higher in intratumoral lesion. It is observed that
angiogenesis in metastasis is higher than in normal tissue but
metastasis is much less vascular. While angiogenesis is higher
than in normal tissue, angiogenic proliferation is very low in the
peritumoral region (14, 15). Therefore, several studies have found
Fig. 1. An example volume of interest (VOI) drawn on an image of glioblastoma (GBM). (1A, 1B) Contrast -enhanced T1-weighted images (CE+
T1WI), (2A, 2B) ASL images (from left, axial, sagittal, and coronal planes) and (1C, 2C) 3D view of VOI. The tumor manifested as a contrast
enhancement on CE+T1WI and a high signal intensity on ASL images. Tumor VOI (green) included only abnormal high signal intensity.
Table 1
GBM (n=25) MET (n=13) P value
Sex (male%) 68 46.15 0.286
Age 67.3610.79 61.2310.21 0.970
Volume difference (ml) 21.5522.12 3.4911.59 0.001
Volume ratio 3.22.4 1.20.89 0.001
TBF (ml/100 g/min) 136.558.16 107.664.93 0.85
TBF ratio 5.662.35 4.262.36 0.69
GBM, glioblastoma multiforme ; MET, metastasis ; TBF, tumor blood flow
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associations of intratumoral vascular shunts with tumor growth,
particularly for GBM (12, 28). Neovascularization related with
tumor development can lead to blood-brain barrier disruption,
which produces leaky vessels with stagnant flow (29). Both of vas-
cular shunts with rapid tracer transit and stagnant blood flow would
give high signal intensity on ASL images (11, 12, 30).
On the other hand, a difference in tumoral edema can affect tracer
transit time in ASL. It is found that a higher degree of surrounding
edema was more likely in metastasis, while GBM produced greater
contrast enhancement. Cerebral edema in patients with metastatic
neoplasms is often vasogenic due to vascular permeability, whereas
GBM often exhibits a combination of cytotoxic edema and cell
infiltration (4, 5, 14). Due to these differences in angiogenesis, we
suspect that a difference in ASL signal stemming from the tumor
Fig. 2. Receiver operating characteristic (ROC) curves for determining the discrimination accuracy of the variables. The volume difference and
volume ratio showed greater sensitivity and specificity for distinguishing GBM from metastasis than absolute maximal tumor blood flow (TBF)
and TBFratioas indicatedbyareas under theROCcurves.
Fig. 3. Glioblastoma with surrounding edema (WHO grade IV) in a 75-year -old male patient. (A) A CE+T1WI showing a solid contrast -enhanced
lesion. (B) The tumor exhibits a large hyperintensity on ASL images.
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itself is unlikely between GBM and MET.
Cerebral blood flow is considered the most reliable measure-
ment parameter of ASL for clinical evaluation (9). In our study,
GBM exhibited a slightly higher TBF than metastasis, but neither
the difference of TBF and TBF ratio reached the level of statistical
significance (Table 1). Previous studies of contrast perfusion MRI
found no significant difference in TBF between malignant glioma
and metastasis (3-5), consistent with our results. It is noted that
both GBM and metastasis are highly vascular malignant tumors,
and specific types of metastasis such as melanoma and renal car-
cinoma may show markedly elevated TBF (3, 6). In the present
study, a metastatic tumor from colon carcinoma showed the high-
est perfusion value by ASL. Alternatively, several studies have re-
ported higher perfusion for malignant glioma than for metastasis
(6), and greater perfusion in the peritumoral region is considered
sufficient to differentiate malignant glial tumors (4, 5). However,
we did not focus on peritumoral regions as these have been ex-
amined in many previous comparative studies on GBM and me-
tastasis. Nevertheless, the major portion of GBM lesions show
surrounding edema (7), while some types of metastases show very
high perfusion (3, 6, 14). It thus appears difficult to differentiate
metastasis from GBM by differences in ASL-measured TBF.
Multiple volumetric parameters derived from conventional MRI
have been investigated for brain tumor evaluation, most assessing
tumor treatment response rather than differentiation of tumor
type. In this study, we used 3D volumetry of ASL, a novel perfusion
method for assessing various cerebral diseases (9). According to
our findings, the combination of volumes of ASL high signal and
contrast enhancement may be useful for differentiating GBM from
metastasis, particularly as the use of ASL is increasing due to other
non-contrast benefits. In addition to diagnostic applications, volu-
metric analysis of ASL signal changes could be used for physi-
ological measurement of microvascular changes, which could be
complemented by traditional sequences for assessment of mor-
phological changes.
Limitations of the study include a relatively small number of
tumor cases, in particular metastasis cases. We also did not con-
sider tumor size, and it is possible that larger metastatic tumors
show more expansive ASL high signal volumes than smaller GBMs
do. The acquisition time of this volumetry method may be longer
than conventional MRI studies due to the need for multiple 3D
imaging datasets (ASL and CE sequences). Furthermore, this
method may be inappropriate for subjects with low signal intensity
lesions on both imaging modalities.
CONCLUSION
We demonstrated that the larger volume of tumoral high signal
intensity on ASL images compared with conventional CE+T1WI
can differentiate GBM from metastasis with relatively high sensi-
tivity and specificity, whereas ASL-derived TBF cannot. Differ-
ences in lesion volume between GBM and metastasis were much
larger on ASL images than conventional CE+T1WI images.
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